TABLE 3 ] .
Univariate Regression | ||||
Variable | No. Patients (N = 91) | % | Subhazard Ratio | P Value |
Age category | ||||
< 60 y | 33 | 36.26 | Reference | … |
60-70 y | 27 | 29.67 | 0.79 | .63 |
> 70 y | 31 | 34.07 | 0.37 | .09 |
Sex | ||||
Male | 65 | 71.43 | Reference | … |
Female | 26 | 28.57 | 1.21 | .67 |
Underlying malignancy | ||||
Other | 35 | 38.46 | Reference | … |
Lymphoma | 56 | 61.54 | 1.06 | .89 |
Chemotherapy activity | ||||
Active | 39 | 42.86 | Reference | … |
Within the past 6 wk | 17 | 18.68 | 1.28 | .65 |
> 6 wk ago | 23 | 25.27 | 0.48 | .27 |
Unknown | 12 | 13.19 | 0.99 | .98 |
Pleural space physiology at IPC placement | ||||
Nonexpandable lung | 15 | 16.48 | Reference | … |
Reexpandable lung | 18 | 19.78 | 2.19 | .35 |
Not assessed | 58 | 63.74 | 1.89 | .39 |
Pleural effusion etiology | ||||
MPE (cytology or histology positive) | 50 | 54.95 | Reference | … |
MPE suspected | 24 | 26.37 | 0.99 | .99 |
Recurrent exudative effusion | 11 | 12.09 | 0.81 | .79 |
Recurrent transudative effusion | 6 | 6.59 | 0.64 | .67 |
MPE = malignant pleural effusion. See Table 2 legend for expansion of other abbreviation.